US Tobacco Companies Challenge California Flavored Tobacco Ban

Nov.30.2022
US Tobacco Companies Challenge California Flavored Tobacco Ban
Tobacco companies challenge California's ban on flavored tobacco products in the US Supreme Court.

On November 29th, tobacco company R.J. Reynolds, also known as Reynold Tobacco Holdings, joined other tobacco companies in a joint request to the United States Supreme Court. They requested an emergency order to block California's ban on flavored tobacco products.


Two years ago, the ban was initially passed by the state legislature, but it never went into effect after tobacco companies collected a significant number of "no" votes. However, nearly two-thirds of voters approved the prohibition of selling electronic cigarette products, and the law will take effect on December 21st.


Supporters of the ban state that this law is necessary to curb the increasing number of young people who smoke.


A study has found that one in six high school students in the United States use e-cigarettes or tobacco products.


Renault filed a federal lawsuit and raised objections to it, but the US 9th Circuit Court of Appeals rejected Renault's emergency motion.


Tobacco giants argue that the authority to ban flavors belongs to federal law. The Family Smoking Prevention and Tobacco Control Act grants the Food and Drug Administration the power to regulate tobacco. These companies are represented by Noel Francisco, who previously served as the top lawyer for the Trump administration at the Supreme Court.


California will become the second state in the United States to implement a ban on the sale of all flavored tobacco products, following in the footsteps of Massachusetts. Several cities in California, including Los Angeles and San Diego, have already implemented their own bans, and a few states have prohibited the sale of flavored electronic cigarette products.


2FIRSTS will continue to provide ongoing coverage of this issue, with updates available on the 2FIRSTS app. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.
Oct.15 by 2FIRSTS.ai
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
The latest data show that in 2024, disposable vape sales in Nova Scotia grew by 25%, and about 16% of residents use vaping products—signaling strong demand for tobacco alternatives. The province’s regulatory framework is forcing retailers to accelerate product-line adjustments and compliance upgrades.
Sep.23 by 2FIRSTS.ai
Decatur, Alabama Passes New Vape Tax: US$0.05–0.10 per mL, Effective October 1
Decatur, Alabama Passes New Vape Tax: US$0.05–0.10 per mL, Effective October 1
The Decatur, Alabama, City Council voted to approve an ordinance imposing a volume-based tax on e-cigarette products: US$0.10 per milliliter for sales within city limits, and US$0.05 per milliliter for sales or deliveries outside city limits but within the city’s police jurisdiction. The ordinance is slated to take effect on October 1, 2025, though the actual start of collection may be set later by a companion resolution.
Sep.16 by 2FIRSTS.ai
Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally
Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally
Bloomberg reports that Japan Tobacco International (JTI) is pursuing a strategy that contrasts with peers such as Philip Morris International (PMI) and British American Tobacco (BAT). While global tobacco majors push “smoke-free” transitions, JTI continues to cultivate combustible cigarettes—particularly value brands in the United States—while advancing the global rollout of its heated-tobacco brand Ploom. JTI forecasts that value-priced cigarettes will exceed a 40% share of the U.S. market by 2
Sep.28 by 2FIRSTS.ai
BAT leaders caution that EU tax hikes may recreate Australia’s ‘black market expansion’ scenario.
BAT leaders caution that EU tax hikes may recreate Australia’s ‘black market expansion’ scenario.
BAT execs warn that steep EU tax hikes on cigarettes and alternatives could spur an Australia-style surge in illicit tobacco, arguing smugglers profit even if 24 of 25 containers are seized; the European Commission disputes this view.
Oct.14